retatrutide clinical trial results weight loss 2024 2025 press release Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Eli Lilly's retatrutide shows promising

For women, it mainly affects the frontal hairline, where hair meets the forehead

Rubino DM, Greenway FL, Khalid U, ONeil PM, Rosenstock J, Srrig R, Wadden TA, Wizert A, Garvey WT, STEP 8 Investigators, Arauz-Pacheco C, Cannon K, Downey HJ, Fitz-Patrick D, Geohas J, Gerety G, Gilbert J, Hollander P, Klein E, Laufer K, ODonnell P, Rosenblit P, Toth P

Physician-prescribed GLP-1 therapy with personalized dosing, available nationwide

Chemo is a potent medication that attacks rapidly diving cells, such as cancer cells, but it may also attack the hair follicles in the scalp and other parts of the body, leading to rapid hair loss

However, fat mass still makes up the majority of weight lost in most patients

They are turning an enormous existing group, women aged 40 to 64 who already make up the majority of filler patients, into first-time cosmetic clients